EGFR and non-small cell lung carcinoma: Previous studies showed that the correlation of change with treatment response was weaker for SUV or SUL than that for summed TLG in patients with non-small-cell lung cancer who were treated with EGFR-TKIs, possibly because of bone flare [24,25].